ENDRA Life Sciences Inc. (NDRA)

$4.12

-0.08 (-1.90%)
Rating:
Recommendation:
Buy
Symbol NDRA
Price $4.12
Beta 0.947
Volume Avg. 0.02M
Market Cap 13.014M
Shares () -
52 Week Range 3.159-12.98
1y Target Est -
DCF Unlevered NDRA DCF ->
DCF Levered NDRA LDCF ->
ROE -26348686.08% Strong Sell
ROA -23157028.29% Strong Sell
Operating Margin -
Debt / Equity 20.97% Neutral
P/E -
P/B 1.28 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NDRA news


Mr. Francois Michelon
Healthcare
Diagnostics & Research
NASDAQ Capital Market

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.